BOSTON SCIENTIFIC CORPORATION Supplier Finance Program Obligation Current
BOSTON SCIENTIFIC CORPORATION (BSX) had Supplier Finance Program Obligation Current of $133.00 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:SupplierFinanceProgramObligationCurrent · last filed 2026-08-03
- 2026-06-30: Supplier Finance Program Obligation Current $133.00M.
- 2026-03-31: Supplier Finance Program Obligation Current $145.00M.
- 2025-12-31: Supplier Finance Program Obligation Current $144.00M.
- 2025-09-30: Supplier Finance Program Obligation Current $151.00M.
| Period end | Supplier Finance Program Obligation Current |
|---|---|
| 2026-06-30 | $133.00M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $145.00M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $144.00M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $151.00M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $139.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $129.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $140.00M 10-Q · filed 2025-11-03 |
| 2024-09-30 | $137.00M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $131.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $140.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $152.00M 10-Q · filed 2024-11-01 |
| 2023-09-30 | $148.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $124.00M 10-Q · filed 2023-08-03 |
| 2022-12-31 | $129.00M 10-Q · filed 2023-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |